University City, MO, United States of America

Ping Shen


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Ping Shen: Innovator in Infectious Virus Research**

Introduction

Ping Shen is a notable inventor based in University City, Missouri, recognized for his significant contributions to the field of virology. With one patent to his name, he has pioneered techniques that enhance the understanding and manipulation of viral vectors, particularly the Sindbis virus.

Latest Patents

Shen's notable patent is titled "Infectious Sindbis virus vectors," which introduces compositions and methods for expressing heterologous coding sequences in host cells. This innovation includes infectious Sindbis virus RNA molecules that contain at least one heterologous coding sequence inserted within the structural region of the Sindbis virus genome. The patent also describes RNA molecules that consist mainly of a Sindbis virus junction region, offering novel methods to express heterologous coding sequences in transformed host cells, as well as procedures for producing infectious Sindbis virus particles containing these RNA molecules.

Career Highlights

Currently affiliated with Washington University, Ping Shen's career is marked by a commitment to advancing research in viral vector development. His work is instrumental in developing innovative methods that could have significant implications for therapeutic applications in viral diseases.

Collaborations

Shen's innovative journey includes collaborations with distinguished peers such as Henry V. Huang and Robin Levis, further enriching the research environment at Washington University. Their collective expertise creates a dynamic team focused on expanding the horizons of virology and genetic engineering.

Conclusion

As an inventor, Ping Shen exemplifies the spirit of innovation within the scientific community. His contributions to the field of infectious diseases, particularly through his patent on Sindbis virus vectors, reflect a deep commitment to advancing scientific knowledge and improving therapeutic practices. Through collaboration and continued research, Shen and his colleagues are poised to make significant impacts in the realm of virology and genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…